masoprocol and EHS Tumor

masoprocol has been researched along with EHS Tumor in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bardal, T; Bjerve, KS; Brekke, OL; Espevik, T1
Kohgo, Y1

Other Studies

2 other study(ies) available for masoprocol and EHS Tumor

ArticleYear
Effects of n-3 and n-6 fatty acids on tumor necrosis factor cytotoxicity in WEHI fibrosarcoma cells.
    Lipids, 1992, Volume: 27, Issue:3

    Topics: Animals; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Cell Survival; Clone Cells; Dexamethasone; Fatty Acids, Nonesterified; Fatty Acids, Unsaturated; Fibrosarcoma; Indomethacin; Kinetics; Lipid Metabolism; Masoprocol; Mice; Phospholipids; Sarcoma, Experimental; Structure-Activity Relationship; Tumor Necrosis Factor-alpha

1992
[Transfer of interleukin 2-activated lymphocytes].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:6 Pt 2

    Topics: Adult; Aged; Animals; Dimethyl Sulfoxide; Ethanol; Female; Fibrosarcoma; Humans; Immunization, Passive; Interleukin-2; Killer Cells, Natural; Lymphocyte Activation; Male; Masoprocol; Mice; Mice, Inbred BALB C; Middle Aged; Neoplasms; Sarcoma, Experimental

1987